Correction: SHP2-mediated mitophagy boosted by lovastatin in neuronal cells alleviates parkinsonism in mice  

作　　者：Wen Liu Meijing Wang Lihong Shen Yuyu Zhu Hongyue Ma Bo Liu Liang Ouyang Wenjie Guo Qiang Xu Yang Sun 

机构地区：[1]不详

出　　处：《Signal Transduction and Targeted Therapy》2025年第1期475-475,共1页信号转导与靶向治疗(英文)

摘　　要：Correction to:Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-021-00474-x,published online 29 January 2021 In the process of collating the raw data,the authors noticed an inadvertent mistakes occurred in Supplementary Fig.11c that need to be corrected after online publication of the article.1 Due to our negligence in extracting and processing a large amount of experimental data,duplicate images were inadvertently used for the MPTP group and the MPTP+lovastatin group of mice with dopaminergic neurons deficient in SHP2(SHP2TH-/-).The correct data are provided as follows.The keyfindings of the article are not affected by these corrections.

关 键 词：LOVASTATIN SHP2 BOOST 

分 类 号：R74[医药卫生—神经病学与精神病学]